#United States #Salt Lake City #Elute Inc #BonVie+ #Spartan Medical

A Strategic Alliance in Medical Innovation

In a recent significant development in the medical technology landscape, Elute, Inc., an innovative leader specializing in drug-eluting devices, has announced a strategic partnership with Spartan Medical Inc.. This collaboration marks a pivotal step toward improving healthcare outcomes, particularly for veterans and active military personnel. With a commitment to delivering advanced medical solutions, this partnership aims to extend the reach of Elute's flagship product, BonVie+™, a bone graft substitute designed to promote healing and recovery in orthopedic procedures.

Bridging the Gap in Veteran Healthcare

Set against the backdrop of the United States' healthcare system, Elute's partnership with Spartan Medical is especially relevant. Spartan Medical Inc. is a veteran-owned and operated service provider specializing in medical solutions for the Department of Veterans Affairs (VA) and the Department of Defense (DoD). Their mission aligns closely with Elute's goal to enhance patient care, making the distribution of BonVie+™ an essential service to medical professionals and patients in need._

The Need for Advanced Bone Graft Solutions

Bone graft substitutes, like BonVie+, are critical in addressing issues caused by traumatic injuries or infections that lead to bone voids. Traditional solutions such as bone cement and calcium sulfate granules have been widely used; however, they present various challenges. For instance, bone cement is non-biodegradable and does not support new bone growth, often prompting a second surgical procedure for removal. Conversely, calcium sulfate substitutes, although resorbable, can lead to complications like seromas—fluid pockets that hinder healing.

Elute's BonVie+™ overcomes these limitations by gradually resorbing and being replaced by the patient’s natural bone, offering a more efficient healing process. According to Dr. Ashok Khandkar, CEO of Elute, this innovation represents over a decade of research and development, significantly enhancing reliability for clinicians and patients alike.

Addressing Surgical Site Infections

Elute’s partnership with Spartan Medical is particularly timely, given the rising concerns regarding surgical site infections (SSIs) after orthopedic surgeries. SSIs can complicate procedures, extending hospital stays and necessitating further surgeries, thus burdening healthcare systems. Spartan Medical is leading a national awareness initiative focusing on the ramifications of these infections, which often range between 1% to 5% in orthopedic surgeries. BonVie+ serves as a vital tool that addresses suboptimal healing linked to infections, improving overall patient outcomes.

Innovative Solutions in the Medical Field

As Vince Proffitt, the Founder and President of Spartan Medical, emphasized, the medical marketplace is saturated with various biologic options. However, the distinction of BonVie+ lies in its unique ability to foster a healing-friendly environment, while also addressing specific challenges faced by surgeons. The implant’s optimal resorption rate mitigates risks associated with prolonged recovery, ultimately leading to better outcomes in complex orthopedic procedures where infection risk is heightened.

Not only does this partnership leverage Spartan Medical’s established federal contracts, but it also emphasizes a commitment to domestic manufacturing, underscoring the importance of providing advanced medical solutions that are made in America.

Looking Ahead

Both Elute, Inc. and Spartan Medical share a common vision: to enhance healthcare delivery, especially for veterans and active service members. As they move forward with their partnership, the focus will remain on fostering innovation and ensuring that cutting-edge medical solutions, such as BonVie+, are readily available.

About BonVie+™
BonVie+™ is a calcium-salt resorbable bone void filler implant used in filling bone defects, promising a natural transition as it is replaced by the patient's own bone tissue over time.

About Elute, Inc.
Elute is at the forefront of drug delivery technology, focusing on developing devices for controlled and extended drug release. Among its notable products is EP Granules with Tobramycin, an investigational device that demonstrates similar benefits to BonVie+ while facilitating localized drug delivery.

About Spartan Medical Inc.
A veteran-operated contractor, Spartan Medical provides comprehensive medical solutions to federal agencies, equipped with experienced professionals dedicated to solving complex healthcare challenges.

This partnership not only stands to improve the landscape of veteran healthcare but also serves as a beacon of hope in the fight against surgical complications through innovative solutions and strategic alliances.